CervoMed

CervoMed is a clinical-stage biotechnology company focused on developing innovative therapies for age-related neurodegenerative and neurological disorders. The companys research is centered on targeting underlying disease mechanisms associated with neuroinflammation and neurodegeneration through the development of novel small-molecule treatments. I... ts lead therapeutic program is being investigated for multiple neurological conditions, including disorders that affect cognition, language, and motor function. Through clinical research and strategic development efforts, CervoMed aims to advance disease-modifying treatments that address significant unmet medical needs and improve outcomes for patients living with progressive brain disorders.Read More